Cargando…

A Novel Strategy for Creating Tissue-Engineered Biomimetic Blood Vessels Using 3D Bioprinting Technology

In this work, a novel strategy was developed to fabricate prevascularized cell-layer blood vessels in thick tissues and small-diameter blood vessel substitutes using three-dimensional (3D) bioprinting technology. These thick vascularized tissues were comprised of cells, a decellularized extracellula...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yuanyuan, Hu, Yingying, Liu, Changyong, Yao, Hongyi, Liu, Boxun, Mi, Shengli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163305/
https://www.ncbi.nlm.nih.gov/pubmed/30200455
http://dx.doi.org/10.3390/ma11091581
_version_ 1783359328797851648
author Xu, Yuanyuan
Hu, Yingying
Liu, Changyong
Yao, Hongyi
Liu, Boxun
Mi, Shengli
author_facet Xu, Yuanyuan
Hu, Yingying
Liu, Changyong
Yao, Hongyi
Liu, Boxun
Mi, Shengli
author_sort Xu, Yuanyuan
collection PubMed
description In this work, a novel strategy was developed to fabricate prevascularized cell-layer blood vessels in thick tissues and small-diameter blood vessel substitutes using three-dimensional (3D) bioprinting technology. These thick vascularized tissues were comprised of cells, a decellularized extracellular matrix (dECM), and a vasculature of multilevel sizes and multibranch architectures. Pluronic F127 (PF 127) was used as a sacrificial material for the formation of the vasculature through a multi-nozzle 3D bioprinting system. After printing, Pluronic F127 was removed to obtain multilevel hollow channels for the attachment of human umbilical vein endothelial cells (HUVECs). To reconstruct functional small-diameter blood vessel substitutes, a supporting scaffold (SE1700) with a double-layer circular structure was first bioprinted. Human aortic vascular smooth muscle cells (HA-VSMCs), HUVECs, and human dermal fibroblasts–neonatal (HDF-n) were separately used to form the media, intima, and adventitia through perfusion into the corresponding location of the supporting scaffold. In particular, the dECM was used as the matrix of the small-diameter blood vessel substitutes. After culture in vitro for 48 h, fluorescent images revealed that cells maintained their viability and that the samples maintained structural integrity. In addition, we analyzed the mechanical properties of the printed scaffold and found that its elastic modulus approximated that of the natural aorta. These findings demonstrate the feasibility of fabricating different kinds of vessels to imitate the structure and function of the human vascular system using 3D bioprinting technology.
format Online
Article
Text
id pubmed-6163305
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61633052018-10-12 A Novel Strategy for Creating Tissue-Engineered Biomimetic Blood Vessels Using 3D Bioprinting Technology Xu, Yuanyuan Hu, Yingying Liu, Changyong Yao, Hongyi Liu, Boxun Mi, Shengli Materials (Basel) Article In this work, a novel strategy was developed to fabricate prevascularized cell-layer blood vessels in thick tissues and small-diameter blood vessel substitutes using three-dimensional (3D) bioprinting technology. These thick vascularized tissues were comprised of cells, a decellularized extracellular matrix (dECM), and a vasculature of multilevel sizes and multibranch architectures. Pluronic F127 (PF 127) was used as a sacrificial material for the formation of the vasculature through a multi-nozzle 3D bioprinting system. After printing, Pluronic F127 was removed to obtain multilevel hollow channels for the attachment of human umbilical vein endothelial cells (HUVECs). To reconstruct functional small-diameter blood vessel substitutes, a supporting scaffold (SE1700) with a double-layer circular structure was first bioprinted. Human aortic vascular smooth muscle cells (HA-VSMCs), HUVECs, and human dermal fibroblasts–neonatal (HDF-n) were separately used to form the media, intima, and adventitia through perfusion into the corresponding location of the supporting scaffold. In particular, the dECM was used as the matrix of the small-diameter blood vessel substitutes. After culture in vitro for 48 h, fluorescent images revealed that cells maintained their viability and that the samples maintained structural integrity. In addition, we analyzed the mechanical properties of the printed scaffold and found that its elastic modulus approximated that of the natural aorta. These findings demonstrate the feasibility of fabricating different kinds of vessels to imitate the structure and function of the human vascular system using 3D bioprinting technology. MDPI 2018-09-01 /pmc/articles/PMC6163305/ /pubmed/30200455 http://dx.doi.org/10.3390/ma11091581 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Xu, Yuanyuan
Hu, Yingying
Liu, Changyong
Yao, Hongyi
Liu, Boxun
Mi, Shengli
A Novel Strategy for Creating Tissue-Engineered Biomimetic Blood Vessels Using 3D Bioprinting Technology
title A Novel Strategy for Creating Tissue-Engineered Biomimetic Blood Vessels Using 3D Bioprinting Technology
title_full A Novel Strategy for Creating Tissue-Engineered Biomimetic Blood Vessels Using 3D Bioprinting Technology
title_fullStr A Novel Strategy for Creating Tissue-Engineered Biomimetic Blood Vessels Using 3D Bioprinting Technology
title_full_unstemmed A Novel Strategy for Creating Tissue-Engineered Biomimetic Blood Vessels Using 3D Bioprinting Technology
title_short A Novel Strategy for Creating Tissue-Engineered Biomimetic Blood Vessels Using 3D Bioprinting Technology
title_sort novel strategy for creating tissue-engineered biomimetic blood vessels using 3d bioprinting technology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163305/
https://www.ncbi.nlm.nih.gov/pubmed/30200455
http://dx.doi.org/10.3390/ma11091581
work_keys_str_mv AT xuyuanyuan anovelstrategyforcreatingtissueengineeredbiomimeticbloodvesselsusing3dbioprintingtechnology
AT huyingying anovelstrategyforcreatingtissueengineeredbiomimeticbloodvesselsusing3dbioprintingtechnology
AT liuchangyong anovelstrategyforcreatingtissueengineeredbiomimeticbloodvesselsusing3dbioprintingtechnology
AT yaohongyi anovelstrategyforcreatingtissueengineeredbiomimeticbloodvesselsusing3dbioprintingtechnology
AT liuboxun anovelstrategyforcreatingtissueengineeredbiomimeticbloodvesselsusing3dbioprintingtechnology
AT mishengli anovelstrategyforcreatingtissueengineeredbiomimeticbloodvesselsusing3dbioprintingtechnology
AT xuyuanyuan novelstrategyforcreatingtissueengineeredbiomimeticbloodvesselsusing3dbioprintingtechnology
AT huyingying novelstrategyforcreatingtissueengineeredbiomimeticbloodvesselsusing3dbioprintingtechnology
AT liuchangyong novelstrategyforcreatingtissueengineeredbiomimeticbloodvesselsusing3dbioprintingtechnology
AT yaohongyi novelstrategyforcreatingtissueengineeredbiomimeticbloodvesselsusing3dbioprintingtechnology
AT liuboxun novelstrategyforcreatingtissueengineeredbiomimeticbloodvesselsusing3dbioprintingtechnology
AT mishengli novelstrategyforcreatingtissueengineeredbiomimeticbloodvesselsusing3dbioprintingtechnology